コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 d radiographic features of patients with SFR meningoencephalitis.
2 negative effects on viral ability to induce meningoencephalitis.
3 V-6) is an important cause of meningitis and meningoencephalitis.
4 an opportunistic fungal pathogen that causes meningoencephalitis.
5 subarachnoid space to induce dramatic viral meningoencephalitis.
6 ic yeast that can invade the brain and cause meningoencephalitis.
7 gen, which provokes the onset of devastating meningoencephalitis.
8 because cryptococcosis commonly presents as meningoencephalitis.
9 ave led to an improvement in morbidity after meningoencephalitis.
10 CNS manifestations: transverse myelitis and meningoencephalitis.
11 at autopsy revealed a widespread necrotizing meningoencephalitis.
12 e study were diagnosed with HHV-6 meningitis/meningoencephalitis.
13 romoted potential adverse effects, including meningoencephalitis.
14 with one developing early minimal lesion SIV meningoencephalitis.
15 2-vaccinated patients, one of whom developed meningoencephalitis.
16 entral nervous system and the development of meningoencephalitis.
17 quito-borne flavivirus that can cause lethal meningoencephalitis.
18 small number of vaccinees, by cell-mediated meningoencephalitis.
19 the morbidity and mortality of cryptococcal meningoencephalitis.
20 can cause neurological disorders, including meningoencephalitis.
21 We postulate this is early cryptococcal meningoencephalitis.
22 stage when 6% of the participants developed meningoencephalitis.
23 imals developed both SV40-associated PML and meningoencephalitis.
24 omised individuals, causing life-threatening meningoencephalitis.
25 ons due to previously untreatable flavivirus meningoencephalitis.
26 relatively common cause of life-threatening meningoencephalitis.
27 abbit model of hematogenous Candida albicans meningoencephalitis.
28 d various organs, most commonly resulting in meningoencephalitis.
29 (11 children, 8 adults) met criteria for SFR meningoencephalitis.
30 he neonatal mouse brain and produce a lethal meningoencephalitis.
31 ith experimental Listeria monocytogenes (LM) meningoencephalitis.
32 lomyelitis, transverse myelitis, and aseptic meningoencephalitis.
33 cal limbic or extralimbic encephalitis and a meningoencephalitis.
34 ent Ebola virus disease and subsequent fatal meningoencephalitis.
35 c role of intracranial hemorrhage in anthrax meningoencephalitis.
36 ntral nervous system, causing meningitis and meningoencephalitis.
37 s that causes severe respiratory disease and meningoencephalitis.
38 mission through breast milk causing neonatal meningoencephalitis.
39 cognitive changes and gait disturbances from meningoencephalitis.
40 an mimic infectious and autoimmune causes of meningoencephalitis.
41 her evaluation as a lead for primary amoebic meningoencephalitis.
42 agent of the rare but fatal primary amoebic meningoencephalitis.
43 cluding ventriculitis, choroid plexitis, and meningoencephalitis.
44 acranial hemorrhage in patients with anthrax meningoencephalitis.
45 multimodal management of hemorrhagic anthrax meningoencephalitis.
46 ng the sustained fungemia, which can lead to meningoencephalitis.
47 a transgenic mouse model of autoimmune GFAP meningoencephalitis.
48 ion via the olfactory nerve causing a severe meningoencephalitis.
49 on include Guillain-Barre syndrome (GBS) and meningoencephalitis.
50 and intervention strategies for cryptococcal meningoencephalitis.
51 has a lethal canine equivalent: necrotizing meningoencephalitis.
52 pathogen that causes life-threatening fungal meningoencephalitis.
53 sseminate to the CNS and cause meningitis or meningoencephalitis.
54 ccharide capsule and causes life-threatening meningoencephalitis.
55 tions to severe sepsis-like presentations or meningoencephalitis.
56 , C. neoformans can lead to life-threatening meningoencephalitis.
57 r-old woman with endophthalmitis followed by meningoencephalitis.
58 ted for investigating possible etiologies of meningoencephalitis.
59 ryptococcus neoformans, a causative agent of meningoencephalitis.
60 aggressive management, succumbed to C gattii meningoencephalitis.
61 tunistic human pathogenic fungus that causes meningoencephalitis.
62 ency in a patient with relapsing C. albicans meningoencephalitis.
63 within 24 hours of admission consistent with meningoencephalitis.
64 promised individuals, causing bacteremia and meningoencephalitis.
65 ent disorder), 8 had encephalitis, and 1 had meningoencephalitis.
66 a, acute disseminated encephalomyelitis, and meningoencephalitis.
67 during pulmonary infection and the onset of meningoencephalitis.
68 HIV/AIDS patients, causing life-threatening meningoencephalitis.
69 ant role in the pathogenesis of cryptococcal meningoencephalitis.
70 to death were hypoxic events (308 [23.2%]), meningoencephalitis (135 [10.2%]), and cerebral malaria
71 phalitis, 4 with isolated meningitis, 3 with meningoencephalitis, 2 with meningoencephalomyelitis, an
73 sociated with ZIKV, including myelitis (4) , meningoencephalitis (5) and fatal encephalitis (6) .
74 65.4% of the programs for pneumonia (69.2%), meningoencephalitis (50%), enteritis (46.2%), colitis (3
75 enterovirus, 10% parechovirus, 8% bacterial meningoencephalitis, 6% influenza, 6% herpes simplex vir
77 ed disease entities: a rapidly fatal primary meningoencephalitis, a chronic granulomatous amoebic enc
79 tral nervous system manifestation of SV40: a meningoencephalitis affecting cerebral gray matter, with
80 consider arboviral infections in unexplained meningoencephalitis after blood transfusion or organ tra
83 t, aged 7 years, died of rapidly progressive meningoencephalitis after local freshwater exposures, wi
87 ningoencephalitis, R35Q for the patient with meningoencephalitis and colitis caused by Candida glabra
88 markably, deletion of Irf5 alone resulted in meningoencephalitis and death on a more protracted timel
89 athogenic yeast that causes life-threatening meningoencephalitis and grows well on mycological media
90 tory responses in patients with cryptococcal meningoencephalitis and have important implications for
91 leri is a causative agent of primary amoebic meningoencephalitis and is highly resistant to current t
92 ions of inflammatory disorders such as viral meningoencephalitis and Lyme neuroborreliosis as well as
94 ored for deleterious side effects, including meningoencephalitis and microhemorrhage, in WT mice and
95 tral nervous system (CNS) is associated with meningoencephalitis and other neurological syndromes and
97 rmans is recognized for its ability to cause meningoencephalitis and pneumonia among immunocompromise
98 s for the development of severe cryptococcal meningoencephalitis and post-infection syndrome in human
99 ce of Cryptococcus neoformans causing fungal meningoencephalitis and regulation of peroxiredoxins, Ts
103 epatitis virus strain A59 (MHV-A59) produces meningoencephalitis and severe hepatitis during acute in
104 and spinal cords demonstrated more prominent meningoencephalitis and the presence of viral antigen in
105 ed 7 years apart from a patient with chronic meningoencephalitis and underlying agammaglobulinemia we
106 tening COVID-19 or influenza, in addition to meningoencephalitis and/or hemophagocytic lymphohistiocy
107 rain conditions (eg, traumatic brain injury, meningoencephalitis, and brain tumors) or discharged to
108 treptococcus iniae is a cause of septicemia, meningoencephalitis, and death in farmed fish and of cel
110 as characterized by gliosis, meningitis, and meningoencephalitis, and glial cells were identified as
113 infiltrates including abscesses, vasculitis, meningoencephalitis, and/or ependymitis; n = 11/23, 48%)
117 cytes and astrocytes are infected in PML and meningoencephalitis, as determined by in situ hybridizat
118 ingoencephalitis was reported in 3 patients, meningoencephalitis associated with colitis was reported
120 August 1999, an unusual cluster of cases of meningoencephalitis associated with muscle weakness was
121 l discharge, ultimately complicated by fatal meningoencephalitis associated with viral persistence.
123 re diagnosed with either HHV-6 meningitis or meningoencephalitis based on HHV-6 detection in CSF, cli
124 hialophora, and Exophiala species, including meningoencephalitis but not colitis caused by Candida an
125 formans disseminates to the brain and causes meningoencephalitis, but the mechanisms by which the pat
126 neonates with overlapping hypoxic events and meningoencephalitis, but there were no patients with ove
127 cumbed to a wasting syndrome and SIV-induced meningoencephalitis by 14 and 33 weeks postinfection.
128 uman pathogen that causes a life-threatening meningoencephalitis by expression of virulence factors s
129 Identification of a particular cause of meningoencephalitis can be challenging owing to the myri
130 is polyvalent antigen distribution in canine meningoencephalitis case brain tissues, were apparent.
131 st Nile fever cases in addition to West Nile meningoencephalitis cases could allow more accurate and
135 d transplant patients who developed a severe meningoencephalitis caused by mosquito-borne West Nile v
137 ed with arenavirus Tacaribe (TCRV) develop a meningoencephalitis characterized by high IFN-gamma and
138 le degrees of nonsuppurative encephalitis or meningoencephalitis, characterized predominantly by peri
140 The morbidity and mortality of cryptococcal meningoencephalitis (CM) in previously healthy, HIV-nega
142 ligible patients), HIV-negative cryptococcal meningoencephalitis (CM) patients underwent comprehensiv
143 alth Organization (WHO), causes cryptococcal meningoencephalitis (CM), the second leading cause of de
146 atients with non-HIV-associated cryptococcal meningoencephalitis complicated by a postinfectious infl
148 se patients is independent of whether or not meningoencephalitis developed and is against the free am
151 rmined for 15 patients during an outbreak of meningoencephalitis due to St. Louis encephalitis (SLE)
153 n in humans was halted because of autoimmune meningoencephalitis, favorable effects on Abeta depositi
154 tion include a rapidly progressive fulminant meningoencephalitis frequently associated with intracran
156 ccus neoformans (Cn), causal agent of fungal meningoencephalitis, has three varieties with variable h
158 mans is the leading cause of death by fungal meningoencephalitis; however, treatment options remain l
159 ning in a hybrid striped bass (HSB) model of meningoencephalitis identified attenuated S. iniae mutan
163 ococcus neoformans causes a life-threatening meningoencephalitis in a significant percentage of AIDS
167 atients with Alzheimer's disease (AD) caused meningoencephalitis in approximately 6% of immunized pat
168 II clinical trial (AN1792) was halted due to meningoencephalitis in approximately 6% of the AD patien
173 ptococcus neoformans (Cn) var. gattii causes meningoencephalitis in healthy individuals, unlike the b
174 aracterized infectious agent associated with meningoencephalitis in horses and sheep led to molecular
176 ptococcus neoformans causes life-threatening meningoencephalitis in humans, but its overall biologica
179 rmans, a pathogenic yeast that causes lethal meningoencephalitis in immunocompromised individuals, pa
180 s (Cn) is an opportunistic yeast that causes meningoencephalitis in immunocompromised individuals.
186 inhalation and causes the most common fungal meningoencephalitis in immunocompromised subjects worldw
192 obal human fungal pathogen that causes fatal meningoencephalitis in mostly immunocompromised individu
193 cases of severe WNV infection complicated by meningoencephalitis in our organ transplant population.
195 iral illness, it can result in a devastating meningoencephalitis in some patient populations, particu
196 , a human trial of Abeta immunization led to meningoencephalitis in some patients and was discontinue
198 EEE, the NA EEEV-infected animals developed meningoencephalitis in the cerebral cortex with some per
202 from brain tissue from cases in which amebic meningoencephalitis is a diagnostic possibility, as well
211 wleri, the causative agent of primary amebic meningoencephalitis, is resistant to complement lysis.
212 umocystis carinii pneumonia, cytomegalovirus meningoencephalitis, lymphoid depletion, and thymic atro
213 m the AN-1792 vaccine trial suggest that the meningoencephalitis may have been caused by a T cell-med
215 cluding those with unrecognized cryptococcal meningoencephalitis may transmit the infection with the
218 patient suffering from Candida dubliniensis meningoencephalitis, mutations in the CARD9 gene were fo
219 titis virus (MHV; murine coronavirus) causes meningoencephalitis, myelitis, and optic neuritis follow
221 athogen responsible for respiratory disease, meningoencephalitis, myocarditis, arthritis, and other s
222 ncluding hydrops fetalis, fetal myocarditis, meningoencephalitis, neurodevelopmental delays, congenit
223 393 cases of laboratory-confirmed West Nile meningoencephalitis occurred in southeast Romania, with
224 In August 2013, a 4-year-old boy died of meningoencephalitis of unknown etiology in a Louisiana h
227 reaks remain unknown, like the recent fungal meningoencephalitis outbreak on Vancouver Island, Canada
228 s known to cause the disease primary amoebic meningoencephalitis (PAM) and can be found in drinking w
229 rvous system infection called primary amebic meningoencephalitis (PAM) in healthy children and young
230 ely low levels of infection, primary amoebic meningoencephalitis (PAM) induced by Naegleria fowleri i
237 ri is the causative agent of primary amoebic meningoencephalitis (PAM), which is fatal in >97% of cas
238 otozoan pathogen that causes primary amoebic meningoencephalitis (PAM), with the death rate exceeding
241 associated with spending more time outdoors (meningoencephalitis patients and asymptomatically seropo
242 lus somnus isolates from cases of thrombotic meningoencephalitis, pneumonia, and other disease sites
243 after approximately 6% of patients developed meningoencephalitis, possibly because of a T-cell reacti
245 the central nervous system and causes fatal meningoencephalitis primarily in patients with AIDS.
246 f M. canis in brains of dogs with idiopathic meningoencephalitis prompted new in vitro studies to hel
247 the 3 patients with Candida albicans-induced meningoencephalitis, R35Q for the patient with meningoen
248 omorbidities but were more likely to develop meningoencephalitis, septic arthritis, and spinal infect
249 to intensive care between 2007 and 2010 with meningoencephalitis, septic illness, or other critical i
250 ative intracellular pathogen responsible for meningoencephalitis, septicemia, and abortion in suscept
252 us (WNV) infection causes a life-threatening meningoencephalitis that becomes increasingly more preva
254 mia from Australia suffering from 3 years of meningoencephalitis that defied an etiologic diagnosis d
255 a rare cause of severe pulmonary disease and meningoencephalitis that has only recently been detected
256 nfecting the central nervous system to cause meningoencephalitis that is uniformly fatal if untreated
257 t to the host environment and to cause fatal meningoencephalitis, thereby identifying the SREBP pathw
258 eas Ehrlichia chaffeensis (HME) often causes meningoencephalitis, this is rare with Anaplasma phagocy
259 ogen, M. canis has the capacity to influence meningoencephalitis through complex interactions within
262 associated with microglia; (iv) T-lymphocyte meningoencephalitis was present; and (v) cerebral white
266 hrough the development of an immune-mediated meningoencephalitis, which predominantly involves the br
268 Cryptococcus gattii species complexes cause meningoencephalitis with high fatality rates and conside
270 ory infection, septic shock, and hemorrhagic meningoencephalitis with severe intracranial hypertensio